Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,937,222

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,937,222
Title:Modulators of complement activity
Abstract: The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.
Inventor(s): Hoarty; Michelle Denise (Billerica, MA), Dhamnaskar; Ketki Ashok (Cambridge, MA), Elbaum; Daniel (Newton, MA), Josephson; Kristopher (Wayland, MA), Larson; Kelley Cronin (Quincy, MA), Ma; Zhong (Lexington, MA), Nims; Nathan Ezekiel (Winchester, MA), Ricardo; Alonso (Cambridge, MA), Seyb; Kathleen (South Boston, MA), Tang; Guo-Qing (Acton, MA), Treco; Douglas A. (Arlington, MA), Wang; Zhaolin (Wellesley, MA), Ye; Ping (Lexington, MA), Zheng; Hong (New York, NY), Perlmutter; Sarah Jacqueline (Medord, MA)
Assignee: Ra Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/547,085
Patent Claims:see list of patent claims

Details for Patent 9,937,222

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Ra Pharmaceuticals, Inc. (Cambridge, MA) 2035-06-12 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
US Department of Justice
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.